British shoe brand Dr. Martens achieved double growth in revenue and EBITDA in all regions, including the EMEA region (Europe, Middle East, Africa).
The company has made significant progress in relation to its strategic plans, especially good indicators were recorded in the Direct to Consumer channel.
“It was a fantastic year for Dr. Martens. We have achieved good results in a number of indicators, with sales growth in all regions and channels with double-digit revenue growth and EBITDA. And all this in the context of the wide economic uncertainty that is present in most of our key markets, which is further evidence of the strength of our brand, our legacy, competent consumer offer and following our strategy, ”says the head of Dr. Martens Paul Mason.
Total revenue increased by 20% and amounted to £ 348,6, EBITDA increased by 33%, up to £ 50 million British pounds. Revenue from direct customer interaction increased by 26%, amounting to £ 140,7 million, retail income increased by 23% to £ 97,1 million and e-commerce revenue increased by 35% to £ 43,6 million. Like for retail sales rose by 7% , and wholesale link revenue grew by 16% and amounted to £ 207,9 million. The growth of these indicators is observed in all regions where the brand is present.
Revenue Dr. Martens in EMEA (Europe, Middle East, Africa) grew by 32%, up to £ 159,9 million. Revenue in the region of America grew by 11% to £ 117.4 million, revenue in the Asian region was 13% to £ 75,3 million.
Throughout the year, Dr. Martens opened 25 new stores, including 9 in the UK, 7 in continental Europe, 3 in the USA, and 6 in Asia. In the same period, the company closed two stores; as a result, the retail network of the Dr. brand Martens includes an 94 store.
Rating |